Generic Saxenda® is the first-ever generic GLP-1 indicated for weight loss, addressing increased demand for this category of therapies in the ...

Teva Pharmaceuticals announced in late August 2025 that it received FDA approval and commenced the U.S. launch of its generic version of Saxenda® (liraglutide injection), which had annual sales of ...

Generic Saxenda® is the first-ever generic GLP-1 indicated for weight loss, addressing increased demand for this category of therapies in the U.S. market.This approval and launch add to Teva's continu ...

Teva Pharmaceuticals has launched the first generic GLP-1 drug for weight loss in adults and adolescents; a lower-cost ...

Teva Pharmaceuticals gained FDA approval to launch the first generic GLP-1 drug for weight loss, a liraglutide injection based on Saxenda.

The Food and Drug Administration is cracking down on ingredients from potentially from unverified foreign sources and that ...

Parsippany: Teva Pharmaceuticals, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd., has announced the FDA approval and U.S. launch of a generic version of Saxenda ...

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) said its U.S. affiliate announced today the FDA approval and U.S. launch of a generic version of Saxenda®1 (liraglutide injection). “With this approval ...

BRITS have been warned about a surge in black market demand for a powerful new drug dubbed the “Godzilla” of fat jabs.

Teva Pharmaceuticals has received FDA approval and has launched a generic version of Saxenda (liraglutide), which is approved to treat adults and adolescents 12 to 17 years of age who are obese or ...

Losing weight can be emotional, but the Cork plant making the active ingredient in weight-loss drug Mounjaro has no room for ...

AS fat jab users panic and race to stock up on Mounjaro, a sharp rise in fake pharmacies will be capitalising on users’ money ...